Oleanolic acid, a pentacyclic triterpene attenuates the mustard oil-induced colonic nociception in mice

Biological and Pharmaceutical Bulletin

Volumn 29, Issue 1, 2006, Pages 82-85

  Maia, Juliana Lemos ^a   Lima Júnior, Roberto César Pereira ^a   David, Juceni Pereira ^b   David, Jorge Mauricio ^b   Santos, Flávia Almeida ^a   Rao, Vietla Satyanarayana ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

Antinociceptive activity; Mustard oil; Oleanolic acid; Pentacyclic triterpene; Visceral nociception

Indexed keywords

ALLYL ISOTHIOCYANATE; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; NALOXONE; OLEANOLIC ACID; OPIATE ANTAGONIST; OPIATE RECEPTOR; RUTHENIUM RED; TRITERPENE DERIVATIVE; VANILLOID RECEPTOR 1; YOHIMBINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENUATION; BEHAVIOR; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG POTENTIATION; MALE; MOBILIZATION; MOUSE; NOCICEPTION; NONHUMAN; PAIN;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; BEHAVIOR, ANIMAL; COLONIC DISEASES; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MOTOR ACTIVITY; MUSTARD PLANT; OLEANOLIC ACID; PAIN; PLANT OILS; RECEPTORS, ADRENERGIC, ALPHA-2; RUTHENIUM RED; TRPV CATION CHANNELS; YOHIMBINE;

EID: 29844453901     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.29.82     Document Type: Article

References (24)

1. Collins S., Gut, 53 (Suppl. II), 19-21 (2004).
2. Davis J. B., Gray J., Gunthorpe M. J., Hatcher J. P., Davey P. T., Harries M. H., Latcham J., Clapham C., Atkinson K., Hughes S. A., Rance K., Grau E., Harper A. J., Pugh P. L., Rogers D. C., Bingham S., Randall A., Sheardown S. A., Nature (London), 405, 183-187 (2000).
3. Caterina M. J., Leffler A., Malmberg A. B., Martin W. J., Trafton J., Petersen-Zeitz K. R., Koltzenburg W. J., Basbaum A. I., Julius D., Science, 288, 306-313 (2000).
4. Ji R. R., Zhang Q., Law P. Y., Low H. H., Elde R., Hokfelt T., J. Neurosci., 15, 8156-8166 (1995).
5. Mansour A., Fox C. A., Akil H., Watson S. J., Trends Neurosci., 18, 22-29 (1995).
6. Sterner O., Szallasi A., Trends Pharmacol. Sci., 20, 459-465 (1999).
7. Oliveira F. A., Vieira-Junior G. M., Chaves M. H., Almeida F. R. C., Santos K. A., Martins F. S., Silva R. M., Santos F. A., Rao V. S. N., Planta Med., 70, 780-782 (2004).
8. Oliveira F. A., Costa C. L., Chaves M. H., Almeida F. R. C., Cavalcante I. J., Lima F., Lima-Júnior R. C. P., Silva R. M., Santos F. A., Rao V. S. N., Life Sci., (2005) (in press).
9. Singh G. B., Singh S., Bani S., Gupta B. D., J. Pharm. Pharmacol., 44, 456-458 (1992).
10. Rodriguez J. A., Astudillo L., Schmeda-Hirchmann G., Pharmacol. Res., 48, 291-294 (2003).
11. Laird J. M. A., Martinez-Caro L., Garcia-Nicas E., Cervero F., Pain, 92, 335-342 (2001).
12. Mayer F. A., Gebhart G. F., Gastroenterology, 107, 271-293 (1994).
13. David J. P., Da Silva E. F., De Moura D. L., Guedes M. L. S., Assunção R. J., David J. M., Quim. Nova., 24, 730-733 (2001).
14. Capaz F. R.,Vanconcellos L. E. M., De Moraes S., Neto J. P., Archiv. Intern. Farmacodyn., 25, 228-236 (1981).
15. Maggi C. A., Lecci A., Santicioli P., Del Bianco E., Auton. Nerv. Syst., 38, 201-208 (1992).
16. Kobayashi Y., Planta Med., 69, 425-428 (2003).
17. Jordt J. E., Bautista D., Chuang H. H., Mckemy D. D., Zygmunt P. M., Hogestatt E. D., Meng I. D., Julius D., Nature (London), 427, 260-265 (2004).
18. Jiang M. C., Gebhart G. F., Pain, 77, 305-313 (1998).
19. Wood J. N., Gut, 53, ii9-12 (2004).
20. Kimball E. S., Palmer J. M., D'Andrea M. R., Hornby P. J., Wade P. R., Am. J. Physiol. Gastroenterol., 288, G1266-1273 (2005).
21. Kapil A., Sharma S., J. Pharm. Pharmacol., 47, 585-587 (1995).
22. Miampamba M., Chery-Croze S., Detolle-Sarbach S., Guez D., Chayvialle J. A., Eur. J. Pharmacol., 308, 251-259 (1996).
23. Blackshaw L. A., Gebhart G. F., Curr. Opin. Pharmacol., 6, 642-649 (2002).
24. Black D., Trevethick M., Gut, 43, 312-313 (1998).